Cargando…
cDC1 prime and are licensed by CD4 T cells to induce anti-tumour immunity
Conventional type 1 dendritic cells (cDC1s(1)) are thought to perform antigen cross-presentation required to prime CD8 T cells(2,3), while cDC2 are considered specialized for priming CD4 T cells(4,5). CD4 T cells are also thought to help CD8 T cell responses through a variety of mechanisms(6–11), in...
Autores principales: | Ferris, Stephen T., Durai, Vivek, Wu, Renee, Theisen, Derek J., Ward, Jeffrey P., Bern, Michael D., Davidson, Jesse T., Bagadia, Prachi, Liu, Tiantian, Briseño, Carlos G., Li, Lijin, Gillanders, William E., Wu, Gregory F., Yokoyama, Wayne M., Murphy, Theresa L., Schreiber, Robert D., Murphy, Kenneth M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469755/ https://www.ncbi.nlm.nih.gov/pubmed/32788723 http://dx.doi.org/10.1038/s41586-020-2611-3 |
Ejemplares similares
-
Notch2-dependent DC2s mediate splenic germinal center responses
por: Briseño, Carlos G., et al.
Publicado: (2018) -
Cryptic activation of an Irf8 enhancer governs cDC1 fate specification
por: Durai, Vivek, et al.
Publicado: (2019) -
Batf3 maintains Irf8 autoactivation for commitment of a CD8α(+) cDC clonogenic progenitor
por: Grajales-Reyes, Gary E., et al.
Publicado: (2015) -
An Nfil3–Zeb2–Id2 pathway imposes Irf8 enhancer switching during cDC1 development
por: Bagadia, Prachi, et al.
Publicado: (2019) -
The role of cDC1s
in vivo: CD8 T cell priming through cross-presentation
por: Theisen, Derek, et al.
Publicado: (2017)